NCT05762939

Brief Summary

This clinical trial compares the effects of using an artificial intelligence based therapy chatbot and a self-help book to lower anxiety and depressive symptoms. The therapy chatbot (named Fido) is an application delivering support for mental health via a conversation-like interface in a highly inflected language (Polish). The team will recruit young people (aged 18-35) who currently struggle with anxiety and/or depression. The participants will use the chatbot or self-help materials for two weeks. Then, the researchers will check if using the chatbot or the book improved several aspects of mental health and the quality of life. Moreover, they will compare the groups for any differences in outcomes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
81

participants targeted

Target at P25-P50 for not_applicable anxiety

Timeline
Completed

Started May 2022

Shorter than P25 for not_applicable anxiety

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 3, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 2, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 2, 2022

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

February 10, 2023

Completed
28 days until next milestone

First Posted

Study publicly available on registry

March 10, 2023

Completed
Last Updated

March 10, 2023

Status Verified

February 1, 2023

Enrollment Period

3 months

First QC Date

February 10, 2023

Last Update Submit

February 27, 2023

Conditions

Keywords

anxietydepressionquality of lifeloneliness

Outcome Measures

Primary Outcomes (7)

  • CESD-R Score Change

    The total sum score of the Polish version of the Center for Epidemiologic Studies Depression Scale Revised.

    Time point 1: Just prior to the intervention. Time point 2: Immediately after two weeks of the intervention. Time point 3: One month after the previous measurement (time point 2).

  • PHQ-9 Score Change

    The total sum score of the Polish version of the Patient Health Questionnaire-9.

    Time point 1: Just prior to the intervention. Time point 2: Immediately after two weeks of the intervention. Time point 3: One month after the previous measurement (time point 2).

  • PSWQ Score Change

    The total sum score of the Polish version of the Penn State Worry Questionnaire.

    Time point 1: Just prior to the intervention. Time point 2: Immediately after two weeks of the intervention. Time point 3: One month after the previous measurement (time point 2).

  • SWLS Score Change

    The total sum score of the Polish version of the Satisfaction With Life Scale.

    Time point 1: Just prior to the intervention. Time point 2: Immediately after two weeks of the intervention. Time point 3: One month after the previous measurement (time point 2).

  • PANAS Score Change

    The total sum scores of the Polish version of the Positive and Negative Affect Scale in two subscales (Positive and Negative Affect, separately).

    Time point 1: Just prior to the intervention. Time point 2: Immediately after two weeks of the intervention. Time point 3: One month after the previous measurement (time point 2).

  • STAI Score Change

    The total sum score of the Polish version of the State-Trait Anxiety Inventory.

    Time point 1: Just prior to the intervention. Time point 2: Immediately after two weeks of the intervention. Time point 3: One month after the previous measurement (time point 2).

  • R-UCLA Score Change

    The total sum score of the Polish version of the Revised UCLA Loneliness Scale.

    Time point 1: Just prior to the intervention. Time point 2: Immediately after two weeks of the intervention. Time point 3: One month after the previous measurement (time point 2).

Other Outcomes (5)

  • ACC Score

    Time point 2: Immediately after two weeks of the intervention.

  • HCI Scores

    Time point 2: Immediately after two weeks of the intervention.

  • LP Score

    Time point 2: Immediately after two weeks of the intervention.

  • +2 more other outcomes

Study Arms (2)

Chatbot

EXPERIMENTAL

Intervention using a pre-release version of Fido (https://fido.aid.pl), Polish AI-based therapy chatbot.

Behavioral: Chatbot

Control (book)

ACTIVE COMPARATOR

Intervention using self-help materials - chapters from a popular book on cognitive therapy, including worksheets.

Behavioral: Control (book)

Interventions

ChatbotBEHAVIORAL

Participants in this condition were asked to use Fido, a Polish therapy chatbot, for two weeks. No minimal requirements of usage time were enforced, but participants had to fill in five engagement check surveys during the intervention period. Each survey had to be completed in less than 24 hours.

Chatbot
Control (book)BEHAVIORAL

Participants in this condition were told to read selected chapters from a self-help book during the two-week intervention period. No minimal requirements of usage time were enforced, but participants had to fill in five engagement check surveys during the intervention period. Each survey had to be completed in less than 24 hours.

Control (book)

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • declaring at least mild depressive or anxiety symptoms by achieving a total score of at least 16 points on Center for Epidemiologic Studies Depression Scale Revised or at least 50 points on Penn State Worry Questionnaire
  • being able to visit the study site in Poznań (Poland) to complete all measurements

You may not qualify if:

  • undergoing psychotherapy, coaching or psychopharmacological treatment
  • being diagnosed with a neurological disorder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Laboratory of Affective Neuroscience in Poznań, SWPS University of Social Sciences and Humanities

Poznan, Greater Poland Voivodeship, 61-719, Poland

Location

Related Publications (12)

  • Tariman JD, Berry DL, Halpenny B, Wolpin S, Schepp K. Validation and testing of the Acceptability E-scale for web-based patient-reported outcomes in cancer care. Appl Nurs Res. 2011 Feb;24(1):53-8. doi: 10.1016/j.apnr.2009.04.003. Epub 2009 Sep 18.

    PMID: 20974066BACKGROUND
  • Russell D, Peplau LA, Cutrona CE. The revised UCLA Loneliness Scale: concurrent and discriminant validity evidence. J Pers Soc Psychol. 1980 Sep;39(3):472-80. doi: 10.1037//0022-3514.39.3.472.

    PMID: 7431205BACKGROUND
  • Munder T, Wilmers F, Leonhart R, Linster HW, Barth J. Working Alliance Inventory-Short Revised (WAI-SR): psychometric properties in outpatients and inpatients. Clin Psychol Psychother. 2010 May-Jun;17(3):231-9. doi: 10.1002/cpp.658.

    PMID: 20013760BACKGROUND
  • Moshe I, Terhorst Y, Philippi P, Domhardt M, Cuijpers P, Cristea I, Pulkki-Raback L, Baumeister H, Sander LB. Digital interventions for the treatment of depression: A meta-analytic review. Psychol Bull. 2021 Aug;147(8):749-786. doi: 10.1037/bul0000334.

    PMID: 34898233BACKGROUND
  • Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13. doi: 10.1046/j.1525-1497.2001.016009606.x.

    PMID: 11556941BACKGROUND
  • Koziara K. Assessment of depressiveness in population. Psychometric evaluation of the Polish version of the CESD-R. Psychiatr Pol. 2016 Dec 23;50(6):1109-1117. doi: 10.12740/PP/61614. English, Polish.

    PMID: 28211550BACKGROUND
  • Fitzpatrick KK, Darcy A, Vierhile M. Delivering Cognitive Behavior Therapy to Young Adults With Symptoms of Depression and Anxiety Using a Fully Automated Conversational Agent (Woebot): A Randomized Controlled Trial. JMIR Ment Health. 2017 Jun 6;4(2):e19. doi: 10.2196/mental.7785.

    PMID: 28588005BACKGROUND
  • Crawford JR, Henry JD. The positive and negative affect schedule (PANAS): construct validity, measurement properties and normative data in a large non-clinical sample. Br J Clin Psychol. 2004 Sep;43(Pt 3):245-65. doi: 10.1348/0144665031752934.

    PMID: 15333231BACKGROUND
  • Meyer TJ, Miller ML, Metzger RL, Borkovec TD. Development and validation of the Penn State Worry Questionnaire. Behav Res Ther. 1990;28(6):487-95. doi: 10.1016/0005-7967(90)90135-6.

    PMID: 2076086BACKGROUND
  • Kusier AO, Folker AP. The Satisfaction with Life Scale: Philosophical Foundation and Practical Limitations. Health Care Anal. 2021 Mar;29(1):21-38. doi: 10.1007/s10728-020-00420-y. Epub 2021 Jan 2.

    PMID: 33386535BACKGROUND
  • Julian LJ. Measures of anxiety: State-Trait Anxiety Inventory (STAI), Beck Anxiety Inventory (BAI), and Hospital Anxiety and Depression Scale-Anxiety (HADS-A). Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11(0 11):S467-72. doi: 10.1002/acr.20561. No abstract available.

    PMID: 22588767BACKGROUND
  • Karkosz S, Szymanski R, Sanna K, Michalowski J. Effectiveness of a Web-based and Mobile Therapy Chatbot on Anxiety and Depressive Symptoms in Subclinical Young Adults: Randomized Controlled Trial. JMIR Form Res. 2024 Mar 20;8:e47960. doi: 10.2196/47960.

Related Links

MeSH Terms

Conditions

Anxiety DisordersDepression

Condition Hierarchy (Ancestors)

Mental DisordersBehavioral SymptomsBehavior

Study Officials

  • Jarosław Michałowski, PhD

    SWPS University of Social Sciences and Humanities, Warsaw, Poland

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 10, 2023

First Posted

March 10, 2023

Study Start

May 3, 2022

Primary Completion

August 2, 2022

Study Completion

August 2, 2022

Last Updated

March 10, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will share

Anonymized data from all enrolled participants will be publicly available in the project's OSF repository.

Shared Documents
ICF, ANALYTIC CODE
Time Frame
IPD and supporting documents will be available as soon as research results are published.
Access Criteria
IPD and supporting documents will be publicly available.

Locations